Broadfin Capital, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$4,207,000
-2.6%
1,611,999
-38.4%
0.87%
+53.0%
Q4 2018$4,321,0002,618,8190.57%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,511,504$11,775,0006.77%
Broadfin Capital, LLC 1,611,999$4,207,0000.87%
Proxima Capital Management, LLC 206,000$538,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 2,201,697$5,746,0000.52%
Nantahala Capital Management 4,485,000$11,706,0000.36%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,799,141$4,696,0000.18%
Wealthstar Advisors, LLC 73,295$192,0000.12%
Spark Investment Management LLC 303,258$791,0000.04%
Allred Capital Management, LLC 24,995$63,0000.04%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$63,0000.03%
View complete list of NEOS THERAPEUTICS INC shareholders